Apollo Hospitals accepts resignation of President - Group Oncology
Apollo Hospitals Enterprise Limited has accepted the resignation of Mr. Dinesh Madhavan, President - Group Oncology and International, effective from the close of business hours on May 30, 2026. The resignation follows earlier discussions and mutually agreed dates. The company disclosed this change in senior management to the Bombay Stock Exchange Ltd and the National Stock Exchange in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015.

*this image is generated using AI for illustrative purposes only.
Apollo Hospitals Enterprise Limited has accepted the resignation of Mr. Dinesh Madhavan, President - Group Oncology and International, effective from the close of business hours on May 30, 2026. The company informed the stock exchanges that Mr. Madhavan, who was a designated senior management personnel, tendered his resignation, which the board has accepted. This development was disclosed to the Bombay Stock Exchange Ltd and the National Stock Exchange in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015.
Details of the Resignation
The cessation of Mr. Dinesh Madhavan's role marks a change in the senior management structure of Apollo Hospitals Enterprise Limited. The resignation was submitted following earlier discussions and mutually agreed dates, as indicated in the communication addressed to the management. The company has processed the resignation and relieved him of his duties effective immediately at the end of business hours on the specified date.
Regulatory Disclosure
The filing provided specific details regarding the change in senior management as required under the relevant circulars issued by the regulatory authority. The disclosure confirmed that the reason for the change was resignation and that no brief profile was necessary as this was not an appointment. The company also clarified that there were no specific disclosures required regarding relationships between directors in this instance.
Key Information
| Particulars | Details |
|---|---|
| Name of the Senior Management Personnel | Mr. Dinesh Madhavan |
| Designation | President – Group Oncology and International |
| Reason for change | Resignation |
| Date of cessation | May 30, 2026 |
The communication was signed by S.M. Krishnan, Senior Vice President - Finance and Company Secretary, on behalf of Apollo Hospitals Enterprise Limited.
Historical Stock Returns for Apollo Hospitals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.83% | -3.04% | +5.18% | +10.54% | +17.12% | +155.89% |
Who will succeed Mr. Dinesh Madhavan as President of Group Oncology and International?
How will this leadership change impact Apollo Hospitals' international expansion strategy?
What are the potential implications for the company's oncology division's growth targets?


































